Agree with most of what you and @blackkkkkkkk, but SI is...

Agree with most of what you and @blackkkkkkkk, but SI is creative, and given his age and that of Dr. Rose, cannot be unaware of the need for succession planning as part of good corporate governance, even though their experience should be highly treasured. An example where a board member subsequently became a highly successful CEO is at Lynas. It is one of many ways in which this planning can be done. I have no inside knowledge but am guessing that as a founder who might have been happy to sell the company to bigpharma a few years ago, SI probably now has a different understanding or vision of how much farther and higher the company can go as an independent entity. That would be based on a realistic assessment of the known and soon to be knowable pathways to regulatory approvals for both Ryoncil and Rex. With these prizes in sight, SI likely knows that he will need to really strengthen the management bench. I believe shareholders, current and prospective, will be pleasantly surprised in the next moves. This is a watershed year as I see it for this company.